JP2014523521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014523521A5 JP2014523521A5 JP2014513770A JP2014513770A JP2014523521A5 JP 2014523521 A5 JP2014523521 A5 JP 2014523521A5 JP 2014513770 A JP2014513770 A JP 2014513770A JP 2014513770 A JP2014513770 A JP 2014513770A JP 2014523521 A5 JP2014523521 A5 JP 2014523521A5
- Authority
- JP
- Japan
- Prior art keywords
- loxl2
- disease
- antibody
- level
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161492210P | 2011-06-01 | 2011-06-01 | |
| US61/492,210 | 2011-06-01 | ||
| US201161550895P | 2011-10-24 | 2011-10-24 | |
| US61/550,895 | 2011-10-24 | ||
| US201161578813P | 2011-12-21 | 2011-12-21 | |
| US61/578,813 | 2011-12-21 | ||
| PCT/US2012/040585 WO2012167181A1 (en) | 2011-06-01 | 2012-06-01 | Lysyl oxidase-like 2 assay and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016115175A Division JP2016164578A (ja) | 2011-06-01 | 2016-06-09 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014523521A JP2014523521A (ja) | 2014-09-11 |
| JP2014523521A5 true JP2014523521A5 (https=) | 2015-06-18 |
Family
ID=46208194
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014513770A Withdrawn JP2014523521A (ja) | 2011-06-01 | 2012-06-01 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
| JP2016115175A Pending JP2016164578A (ja) | 2011-06-01 | 2016-06-09 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
| JP2017221000A Pending JP2018049033A (ja) | 2011-06-01 | 2017-11-16 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016115175A Pending JP2016164578A (ja) | 2011-06-01 | 2016-06-09 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
| JP2017221000A Pending JP2018049033A (ja) | 2011-06-01 | 2017-11-16 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20120309020A1 (https=) |
| EP (1) | EP2714744A1 (https=) |
| JP (3) | JP2014523521A (https=) |
| KR (1) | KR20140048156A (https=) |
| CN (1) | CN103946241A (https=) |
| AP (1) | AP2013007285A0 (https=) |
| AR (1) | AR086657A1 (https=) |
| AU (2) | AU2012261883A1 (https=) |
| BR (1) | BR112013030682A2 (https=) |
| CA (1) | CA2837534A1 (https=) |
| CL (1) | CL2013003445A1 (https=) |
| CO (1) | CO6940375A2 (https=) |
| CR (1) | CR20130657A (https=) |
| EA (1) | EA201391627A1 (https=) |
| EC (1) | ECSP13013092A (https=) |
| IL (1) | IL229631A0 (https=) |
| MA (1) | MA35212B1 (https=) |
| MD (1) | MD20130098A2 (https=) |
| MX (1) | MX2013013905A (https=) |
| PE (1) | PE20141450A1 (https=) |
| PH (1) | PH12013502490A1 (https=) |
| TW (1) | TW201319572A (https=) |
| UY (1) | UY34115A (https=) |
| WO (1) | WO2012167181A1 (https=) |
| ZA (1) | ZA201308812B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| ES2700141T3 (es) | 2007-08-02 | 2019-02-14 | Gilead Biologics Inc | Anticuerpos inhibidores LOXL2 y usos de los mismos |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| SG178845A1 (en) | 2009-08-21 | 2012-04-27 | Gilead Biologics Inc | Catalytic domains from lysyl oxidase and loxl2 |
| BR112012019693A2 (pt) * | 2010-02-04 | 2017-06-20 | Gilead Biologics Inc | anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles. |
| SG11201503065PA (en) * | 2012-10-30 | 2015-05-28 | Gilead Sciences Inc | Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2) |
| WO2015187499A1 (en) | 2014-06-03 | 2015-12-10 | Gilead Sciences, Inc. | Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor |
| KR20170018383A (ko) * | 2014-06-11 | 2017-02-17 | 길리애드 사이언시즈, 인코포레이티드 | 심혈관 질환의 치료 방법 |
| MA41252A (fr) | 2014-12-23 | 2017-10-31 | Gilead Sciences Inc | Formes solides d'un inhibiteur d'ask 1 |
| AU2017228371A1 (en) | 2016-03-04 | 2018-09-13 | Gilead Sciences, Inc. | Compositions and combinations of autotaxin inhibitors |
| EP3440113A1 (en) | 2016-04-08 | 2019-02-13 | Gilead Sciences, Inc. | Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases |
| GB201704206D0 (en) | 2017-03-16 | 2017-05-03 | Nordic Bioscience As | Lysyl oxidase like-2 assay |
| US20230152330A1 (en) * | 2021-11-17 | 2023-05-18 | AmMax Bio, Inc. | Detection and treatment of idiopathic pulmonary fibrosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6352862B1 (en) * | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| FI92882C (fi) * | 1992-12-29 | 1995-01-10 | Medix Biochemica Ab Oy | Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi |
| US20030114410A1 (en) * | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| ES2700141T3 (es) * | 2007-08-02 | 2019-02-14 | Gilead Biologics Inc | Anticuerpos inhibidores LOXL2 y usos de los mismos |
| JP2010038735A (ja) * | 2008-08-05 | 2010-02-18 | Terumo Corp | 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙 |
| NZ625850A (en) * | 2009-08-21 | 2015-12-24 | Gilead Biologics Inc | Methods and compositions for treatment of pulmonary fibrotic disorders |
| BR112012019693A2 (pt) * | 2010-02-04 | 2017-06-20 | Gilead Biologics Inc | anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles. |
| WO2012154432A2 (en) * | 2011-05-10 | 2012-11-15 | Borgwarner Inc. | Turbocharger with variable turbine geometry |
-
2012
- 2012-06-01 UY UY0001034115A patent/UY34115A/es not_active Application Discontinuation
- 2012-06-01 PH PH1/2013/502490A patent/PH12013502490A1/en unknown
- 2012-06-01 MD MDA20130098A patent/MD20130098A2/ro not_active Application Discontinuation
- 2012-06-01 BR BR112013030682A patent/BR112013030682A2/pt not_active IP Right Cessation
- 2012-06-01 CN CN201280037235.7A patent/CN103946241A/zh active Pending
- 2012-06-01 AU AU2012261883A patent/AU2012261883A1/en not_active Abandoned
- 2012-06-01 CA CA2837534A patent/CA2837534A1/en not_active Abandoned
- 2012-06-01 US US13/487,109 patent/US20120309020A1/en not_active Abandoned
- 2012-06-01 EP EP12725601.4A patent/EP2714744A1/en not_active Withdrawn
- 2012-06-01 TW TW101119847A patent/TW201319572A/zh unknown
- 2012-06-01 JP JP2014513770A patent/JP2014523521A/ja not_active Withdrawn
- 2012-06-01 KR KR1020137034711A patent/KR20140048156A/ko not_active Withdrawn
- 2012-06-01 EA EA201391627A patent/EA201391627A1/ru unknown
- 2012-06-01 AR ARP120101959A patent/AR086657A1/es unknown
- 2012-06-01 AP AP2013007285A patent/AP2013007285A0/xx unknown
- 2012-06-01 MX MX2013013905A patent/MX2013013905A/es not_active Application Discontinuation
- 2012-06-01 US US14/122,984 patent/US20140206017A1/en not_active Abandoned
- 2012-06-01 PE PE2013002739A patent/PE20141450A1/es not_active Application Discontinuation
- 2012-06-01 WO PCT/US2012/040585 patent/WO2012167181A1/en not_active Ceased
-
2013
- 2013-11-25 ZA ZA2013/08812A patent/ZA201308812B/en unknown
- 2013-11-26 IL IL229631A patent/IL229631A0/en unknown
- 2013-11-29 CL CL2013003445A patent/CL2013003445A1/es unknown
- 2013-12-13 CR CR20130657A patent/CR20130657A/es unknown
- 2013-12-19 EC ECSP13013092 patent/ECSP13013092A/es unknown
- 2013-12-27 CO CO13301122A patent/CO6940375A2/es unknown
- 2013-12-30 MA MA36627A patent/MA35212B1/fr unknown
-
2016
- 2016-06-09 JP JP2016115175A patent/JP2016164578A/ja active Pending
- 2016-10-12 AU AU2016244254A patent/AU2016244254B2/en not_active Ceased
- 2016-12-01 US US15/366,986 patent/US20170269085A1/en not_active Abandoned
-
2017
- 2017-11-16 JP JP2017221000A patent/JP2018049033A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014523521A5 (https=) | ||
| Plebani et al. | SARS-CoV-2 serosurvey in health care workers of the Veneto Region | |
| Adams | Biomarkers of liver fibrosis | |
| Mukherjee et al. | Diagnosis and management of hepatitis C virus infection | |
| NO20076656L (no) | Forbedrede immunoassay metoder | |
| JP2016538545A5 (https=) | ||
| Roux et al. | Characteristics of donor-specific antibodies associated with antibody-mediated rejection in lung transplantation | |
| JP2012525855A5 (https=) | ||
| Schenz et al. | Molecular and biomarker-based diagnostics in early sepsis: current challenges and future perspectives | |
| JP2018049033A (ja) | リシルオキシダーゼ様２のアッセイおよびその使用の方法 | |
| Panteghini et al. | Total error vs. measurement uncertainty: the match continues | |
| Lin et al. | Plasma protein biosignatures for detection of cardiac allograft vasculopathy | |
| CN107406510A (zh) | 前列腺抗原标准品及其用途 | |
| Morio et al. | Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury | |
| Erek-Toprak et al. | Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes | |
| Tamura et al. | Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma | |
| Burrello et al. | Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles | |
| US20250130237A1 (en) | Point of Care Assays | |
| Hu et al. | Detection of hepatitis B virus PreS1 antigen using a time-resolved fluoroimmunoassay | |
| Leli et al. | A prediction model for real-time PCR results in blood samples from febrile patients with suspected sepsis | |
| Nomikou et al. | Soluble CD146, a novel endothelial marker, is related to the severity of liver disease | |
| Enomoto et al. | An increased ratio of glycated albumin to HbA1c is associated with the degree of liver fibrosis in hepatitis B virus‐positive patients | |
| JP6876301B2 (ja) | 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット | |
| Cut et al. | Autopsy Findings and Inflammatory Markers in SARS-CoV-2: A Single-Center Experience | |
| Kwon et al. | Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma |